-
Author James Forsythe , Burton Goldberg
Cancer rates continue to skyrocket, and the overall survival rate for Stage IV cancer patients in the United States is a grim 2.1 percent. Clearly, the extensive use of expensive, sometimes ineffective toxins in conventional oncology protocols is a failing strategy.....
Release Date 2012/05